UB Paderborn / Katalog / Suche / in CDI

Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects

Clinical pharmacology in drug development, 2018-01, Vol.7 (1), p.9-21

2018

Link zum Volltext

Verfügbarkeit prüfen

First‐in‐Human, Single‐ and Multiple‐Ascending‐Dose, Food‐Effect, and Absolute Bioavailability Trials to Assess the Pharmacokinetics, Safety, and Tolerability of Pritelivir, a Nonnucleoside Helicase‐Primase Inhibitor Against Herpes Simplex Virus in Healthy Subjects

Clinical pharmacology in drug development, 2023-07, Vol.12 (7), p.749-760

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Safety of Letermovir and Midazolam Coadministration in Healthy Subjects

Clinical pharmacology in drug development, 2022-01, Vol.11 (1), p.16-24

2022

Link zum Volltext

Verfügbarkeit prüfen

New Drug Development for Known and Emerging Viruses

1, 2022

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Oral Letermovir Administration on the Pharmacokinetics of a Single Oral Dose of P‐Glycoprotein Substrate Digoxin in Healthy Volunteers

Clinical pharmacology in drug development, 2022-01, Vol.11 (1), p.6-15

2022

Link zum Volltext

Verfügbarkeit prüfen

AAA+ chaperones and acyldepsipeptides activate the ClpP protease via conformational control

Nature communications, 2015-02, Vol.6 (1), Article 6320

2015

Link zum Volltext

Verfügbarkeit prüfen

Wenn Antibiotika nicht mehr helfen

Biospektrum, 2014-06, Vol.20 (4), p.367-367

Rübsamen-Schaeff, Helga

2014

Link zum Volltext

Verfügbarkeit prüfen

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

The New England journal of medicine, 2014-05, Vol.370 (19), p.1781-1789

2014

Link zum Volltext

Verfügbarkeit prüfen

Structures of ClpP in complex with acyldepsipeptide antibiotics reveal its activation mechanism

Nature structural & molecular biology, 2010-04, Vol.17 (4), p.471

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and safety of letermovir, a novel anti‐human cytomegalovirus drug, in patients with renal impairment

British journal of clinical pharmacology, 2017-09, Vol.83 (9), p.1944-1953

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and safety of the anti‐human cytomegalovirus drug letermovir in subjects with hepatic impairment

British journal of clinical pharmacology, 2017-12, Vol.83 (12), p.2678-2686

2017

Link zum Volltext

Verfügbarkeit prüfen

Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study

Transplant international, 2014-01, Vol.27 (1), p.77-86

2014

Link zum Volltext

Verfügbarkeit prüfen

From academic research to founding a company: the story of AiCuris

Pure and applied chemistry, 2019-04, Vol.91 (4), p.717-728

Rübsamen-Schaeff, Helga

2019

Link zum Volltext

Verfügbarkeit prüfen

Overcoming fragmentation of health research in Europe: lessons from COVID-19

The Lancet (British edition), 2020-06, Vol.395 (10242), p.1970-1971

2020

Link zum Volltext

Verfügbarkeit prüfen